Inozyme Pharma to Participate at the 23rd Annual Needham Virtual Healthcare Conference

April 2, 2024

https://www.globenewswire.com/news-release/2024/04/02/2855974/0/en/Inozyme-Pharma-to-Participate-at-the-23rd-Annual-Needham-Virtual-Healthcare-Conference.html

BOSTON, April 02, 2024 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq:INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today announced that Doug Treco, Ph.D., the company’s chief executive officer and chairman of the board, will participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9, 2024 from 10:15-10:55 a.m. ET.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.